The sale of the $220M revenue MatrixCare business will leave ResMed with 'stranded costs' from shared systems and processes.
Filing excerpt
On July 7, 2026, ResMed Inc. (the “Company” or “Resmed”) issued a press release announcing that on June 30, 2026 it entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused exclusively on healthcare.
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
sec-8krestructuringChargeGet every 8-K signal for ResMed and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at ResMed this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/c183afa4-a2ee-4c2c-aa4b-86d326cc57fa returns this record as JSON. POST /v1/companies/enrich returns every signal for resmed.com.
{
"signal_id": "c183afa4-a2ee-4c2c-aa4b-86d326cc57fa",
"signal_type": "sec-8k",
"signal_subtype": "restructuringCharge",
"detected_at": "2026-07-14T07:08:46.108+00:00",
"company": {
"name": "ResMed",
"domain": "resmed.com"
},
"data": {
"detail": "The sale of the $220M revenue MatrixCare business will leave ResMed with 'stranded costs' from shared systems and processes. This creates an urgent need to consolidate IT infrastructure, streamline operations, and eliminate redundant overhead to maintain profitability post-transaction.",
"metrics": {
"timeframe": "next_quarter",
"dollar_context": "all-cash transaction for the sale of its MatrixCare business",
"dollar_millions": 490
},
"summary": "ResMed divests MatrixCare business for $490M, creating need to eliminate stranded operational costs.",
"excerpts": "On July 7, 2026, ResMed Inc. (the “Company” or “Resmed”) issued a press release announcing that on June 30, 2026 it entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused exclusively on healthcare.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/943819/000119312526297658/d88958d8k.htm",
"filing_date": "2026-07-07",
"filing_year": 2026,
"sales_relevance": "Vendor review likely",
"signal_category": "financial",
"vendors_mentioned": [
"Frazier Healthcare Partners"
]
}
}
curl https://signals.autobound.ai/v1/signals/c183afa4-a2ee-4c2c-aa4b-86d326cc57fa \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"resmed.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.